CEL-SCI (FRA:LSR) Net Loan


FRA:LSR CEL-SCI Corp FRA:LSR
23 GF Score
Price €1.10
! 2 Warning Signs
View Full Analysis

What is CEL-SCI Net Loan?

Net Loan only applies to banks and insurance companies.

FRA:LSR
23GF Score
CEL-SCI Corp FRA:LSR
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CEL-SCI Business Description

Other Exchanges CVM:USA
Address 8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
23GF Score

Get the complete analysis for FRA:LSR

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.10
Price